| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.804 | 3.711 | 5.378 | 5.634 | 1.140 | 424 | 3.664 | 0 | 0 | 0 |
| Total Income - EUR | 3.804 | 3.711 | 5.378 | 5.634 | 1.140 | 424 | 3.664 | 0 | 0 | 0 |
| Total Expenses - EUR | 3.095 | 1.610 | 1.429 | 5.305 | 2.023 | 958 | 1.296 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 710 | 2.101 | 3.949 | 329 | -883 | -534 | 2.368 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 596 | 1.990 | 3.788 | 160 | -918 | -547 | 2.260 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dermgin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 25 | 1.526 | 5.305 | 5.376 | 4.331 | 3.723 | 5.972 | 5.894 | 5.876 | 5.843 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 2.714 | 2.723 | 2.715 | 2.699 |
| Cash | 25 | 1.526 | 5.305 | 5.376 | 4.331 | 3.723 | 3.257 | 3.171 | 3.162 | 3.144 |
| Shareholders Funds | -471 | 1.524 | 5.286 | 5.349 | 4.328 | 3.700 | 5.876 | 5.894 | 5.876 | 5.843 |
| Social Capital | 2.747 | 2.719 | 2.673 | 2.624 | 2.573 | 2.524 | 2.466 | 2.474 | 2.466 | 2.453 |
| Debts | 496 | 2 | 20 | 27 | 3 | 23 | 96 | 0 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermgin Srl